These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
627 related items for PubMed ID: 21934399
1. INI1-deficient tumors: diagnostic features and molecular genetics. Hollmann TJ, Hornick JL. Am J Surg Pathol; 2011 Oct; 35(10):e47-63. PubMed ID: 21934399 [Abstract] [Full Text] [Related]
2. ERG and SALL4 expressions in SMARCB1/INI1-deficient tumors: a useful tool for distinguishing epithelioid sarcoma from malignant rhabdoid tumor. Kohashi K, Yamada Y, Hotokebuchi Y, Yamamoto H, Taguchi T, Iwamoto Y, Oda Y. Hum Pathol; 2015 Feb; 46(2):225-30. PubMed ID: 25479928 [Abstract] [Full Text] [Related]
3. Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor. Kohashi K, Izumi T, Oda Y, Yamamoto H, Tamiya S, Taguchi T, Iwamoto Y, Hasegawa T, Tsuneyoshi M. Hum Pathol; 2009 Mar; 40(3):349-55. PubMed ID: 18973917 [Abstract] [Full Text] [Related]
4. Utility of characteristic 'Weak to Absent' INI1/SMARCB1/BAF47 expression in diagnosis of synovial sarcomas. Rekhi B, Vogel U. APMIS; 2015 Jul; 123(7):618-28. PubMed ID: 25912315 [Abstract] [Full Text] [Related]
5. SMARCB1-deficient Tumors of Childhood: A Practical Guide. Pawel BR. Pediatr Dev Pathol; 2018 Jul; 21(1):6-28. PubMed ID: 29280680 [Abstract] [Full Text] [Related]
6. Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma. Hornick JL, Dal Cin P, Fletcher CD. Am J Surg Pathol; 2009 Apr; 33(4):542-50. PubMed ID: 19033866 [Abstract] [Full Text] [Related]
7. Immunohistochemical analysis of hSNF5/INI1 distinguishes renal and extra-renal malignant rhabdoid tumors from other pediatric soft tissue tumors. Hoot AC, Russo P, Judkins AR, Perlman EJ, Biegel JA. Am J Surg Pathol; 2004 Nov; 28(11):1485-91. PubMed ID: 15489652 [Abstract] [Full Text] [Related]
8. Immunohistochemical validation of INI1/SMARCB1 in a spectrum of musculoskeletal tumors: an experience at a Tertiary Cancer Referral Centre. Rekhi B, Jambhekar NA. Pathol Res Pract; 2013 Dec; 209(12):758-66. PubMed ID: 24075062 [Abstract] [Full Text] [Related]
9. Absence of expression of SMARCB1/INI1 in malignant rhabdoid tumors of the central nervous system, kidneys and soft tissue: an immunohistochemical study with implications for diagnosis. Sigauke E, Rakheja D, Maddox DL, Hladik CL, White CL, Timmons CF, Raisanen J. Mod Pathol; 2006 May; 19(5):717-25. PubMed ID: 16528370 [Abstract] [Full Text] [Related]
10. Soft tissue myoepithelial carcinoma with rhabdoid-like features and EWSR1 rearrangement: Fine needle aspiration cytology with histologic correlation. Machado I, López-Soto MV, Rubio L, Navarro L, Llombart-Bosch A. Diagn Cytopathol; 2015 May; 43(5):421-6. PubMed ID: 25693574 [Abstract] [Full Text] [Related]
11. SMARCB1/INI1 protein expression in round cell soft tissue sarcomas associated with chromosomal translocations involving EWS: a special reference to SMARCB1/INI1 negative variant extraskeletal myxoid chondrosarcoma. Kohashi K, Oda Y, Yamamoto H, Tamiya S, Oshiro Y, Izumi T, Taguchi T, Tsuneyoshi M. Am J Surg Pathol; 2008 Aug; 32(8):1168-74. PubMed ID: 18580682 [Abstract] [Full Text] [Related]
12. Proximal-type epithelioid sarcoma of the vulva with INI1 diagnostic utility. Kim HJ, Kim MH, Kwon J, Kim JY, Park K, Ro JY. Ann Diagn Pathol; 2012 Oct; 16(5):411-5. PubMed ID: 21724432 [Abstract] [Full Text] [Related]
13. Re: Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor: Direct evidence of mutational inactivation of SMARCB1/INI1 in epithelioid sarcoma. Flucke U, Slootweg PJ, Mentzel T, Pauwels P, Hulsebos TJ. Hum Pathol; 2009 Sep; 40(9):1361-2; author reply 1362-4. PubMed ID: 19683621 [No Abstract] [Full Text] [Related]
14. hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities. Bourdeaut F, Fréneaux P, Thuille B, Lellouch-Tubiana A, Nicolas A, Couturier J, Pierron G, Sainte-Rose C, Bergeron C, Bouvier R, Rialland X, Laurence V, Michon J, Sastre-Garau X, Delattre O. J Pathol; 2007 Feb; 211(3):323-30. PubMed ID: 17152049 [Abstract] [Full Text] [Related]
15. [Rhadboid tumours: hSNF/INI1 deficient cancers of early childhood with aggressive behaviour]. Bourdeaut F, Dufour C, Delattre O. Bull Cancer; 2010 Jan; 97(1):37-45. PubMed ID: 20080459 [Abstract] [Full Text] [Related]
16. Concurrent loss of INI1, PBRM1, and BRM expression in epithelioid sarcoma: implications for the cocontributions of multiple SWI/SNF complex members to pathogenesis. Li L, Fan XS, Xia QY, Rao Q, Liu B, Yu B, Shi QL, Lu ZF, Zhou XJ. Hum Pathol; 2014 Nov; 45(11):2247-54. PubMed ID: 25200863 [Abstract] [Full Text] [Related]
17. Immunohistochemistry of INI1 expression: a new tool for old challenges in CNS and soft tissue pathology. Judkins AR. Adv Anat Pathol; 2007 Sep; 14(5):335-9. PubMed ID: 17717433 [Abstract] [Full Text] [Related]
18. Claudin-4 expression distinguishes SWI/SNF complex-deficient undifferentiated carcinomas from sarcomas. Schaefer IM, Agaimy A, Fletcher CD, Hornick JL. Mod Pathol; 2017 Apr; 30(4):539-548. PubMed ID: 28084340 [Abstract] [Full Text] [Related]
19. SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas. Modena P, Lualdi E, Facchinetti F, Galli L, Teixeira MR, Pilotti S, Sozzi G. Cancer Res; 2005 May 15; 65(10):4012-9. PubMed ID: 15899790 [Abstract] [Full Text] [Related]
20. The expanding family of SMARCB1(INI1)-deficient neoplasia: implications of phenotypic, biological, and molecular heterogeneity. Agaimy A. Adv Anat Pathol; 2014 Nov 15; 21(6):394-410. PubMed ID: 25299309 [Abstract] [Full Text] [Related] Page: [Next] [New Search]